Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 128

1.

E2F3a gene expression has prognostic significance in childhood acute lymphoblastic leukemia.

Wang KL, Mei YY, Cui L, Zhao XX, Li WJ, Gao C, Liu SG, Jiao Y, Liu FF, Wu MY, Ding W, Li ZG.

Eur J Haematol. 2014 Oct;93(4):281-9. doi: 10.1111/ejh.12341. Epub 2014 May 16.

PMID:
24758291
2.
3.

Ikaros (IKZF1) alterations and minimal residual disease at day 15 assessed by flow cytometry predict prognosis of childhood BCR/ABL-negative acute lymphoblastic leukemia.

Volejnikova J, Mejstrikova E, Dörge P, Meissner B, Zimmermannova O, Svojgr K, Stanulla M, Cario G, Schrappe M, Stary J, Hrusak O, Trka J, Fronkova E.

Pediatr Blood Cancer. 2013 Mar;60(3):420-7. doi: 10.1002/pbc.24299. Epub 2012 Sep 19.

PMID:
22997141
4.

Incidence and clinical outcome of children with BCR/ABL-positive acute lymphoblastic leukemia (ALL). A prospective RT-PCR study based on 673 patients enrolled in the German pediatric multicenter therapy trials ALL-BFM-90 and CoALL-05-92.

Schlieben S, Borkhardt A, Reinisch I, Ritterbach J, Janssen JW, Ratei R, Schrappe M, Repp R, Zimmermann M, Kabisch H, Janka-Schaub G, Bartram CR, Ludwig WD, Riehm H, Lampert F, Harbott J.

Leukemia. 1996 Jun;10(6):957-63.

PMID:
8667652
5.

[Detection of BCR/ABL, MLL/AF4 and TEL/AML1 hybrid genes and monitoring of minimal residual disease in pediatric patients with acute lymphoblastic leukemia].

Trka J, Zuna J, Haskovec C, Brabencová A, Kalinová M, Muzíková K, Paukertová R, Hrusák O, Zemanová Z, Michalová K, Starý J.

Cas Lek Cesk. 1999 Jan 4;138(1):12-7. Czech.

PMID:
10953429
6.

Clearance of minimal residual disease after allogeneic stem cell transplantation and the prediction of the clinical outcome of adult patients with high-risk acute lymphoblastic leukemia.

Spinelli O, Peruta B, Tosi M, Guerini V, Salvi A, Zanotti MC, Oldani E, Grassi A, Intermesoli T, Micò C, Rossi G, Fabris P, Lambertenghi-Deliliers G, Angelucci E, Barbui T, Bassan R, Rambaldi A.

Haematologica. 2007 May;92(5):612-8.

7.

[Clinical importance of minimal residual disease testing in the therapy of childhood B-cell acute lymphoblastic leukemia].

Ye QD, Gu LJ, Tang JY, Xue HL, Chen J, Pan C, Chen J, Dong L, Zhou M, Jiang LM.

Zhongguo Dang Dai Er Ke Za Zhi. 2008 Jun;10(3):333-6. Chinese.

PMID:
18554462
8.

Minimal residual disease-guided treatment deintensification for children with acute lymphoblastic leukemia: results from the Malaysia-Singapore acute lymphoblastic leukemia 2003 study.

Yeoh AE, Ariffin H, Chai EL, Kwok CS, Chan YH, Ponnudurai K, Campana D, Tan PL, Chan MY, Kham SK, Chong LA, Tan AM, Lin HP, Quah TC.

J Clin Oncol. 2012 Jul 1;30(19):2384-92. doi: 10.1200/JCO.2011.40.5936. Epub 2012 May 21.

9.

Significant reduction of the hybrid BCR/ABL transcripts after induction and consolidation therapy is a powerful predictor of treatment response in adult Philadelphia-positive acute lymphoblastic leukemia.

Pane F, Cimino G, Izzo B, Camera A, Vitale A, Quintarelli C, Picardi M, Specchia G, Mancini M, Cuneo A, Mecucci C, Martinelli G, Saglio G, Rotoli B, Mandelli F, Salvatore F, Foà R; GIMEMA group.

Leukemia. 2005 Apr;19(4):628-35.

PMID:
15744351
10.

[Clinical significance of glucocorticoid induction test in Chinese childhood acute lymphoblastic leukemia].

Fan JJ, Chai YH, Hu SY, He HL, Zhao WL, Wang Y, Li J, Lu J, Xiao PF, Sun YN, Wang W, Cao L.

Zhonghua Er Ke Za Zhi. 2013 Jul;51(7):523-6. Chinese.

PMID:
24267134
11.

Minimal residual disease-based risk stratification in Chinese childhood acute lymphoblastic leukemia by flow cytometry and plasma DNA quantitative polymerase chain reaction.

Cheng SH, Lau KM, Li CK, Chan NP, Ip RK, Cheng CK, Lee V, Shing MM, Leung AW, Ha SY, Cheuk DK, Lee AC, Li CH, Luk CW, Ling SC, Hrusak O, Mejstrikova E, Leung Y, Ng MH.

PLoS One. 2013 Jul 25;8(7):e69467. doi: 10.1371/journal.pone.0069467. Print 2013.

12.

Prognostic value of MRD-dynamics in childhood acute lymphoblastic leukemia treated according to the MB-2002/2008 protocols.

Meleshko AN, Savva NN, Fedasenka UU, Romancova AS, Krasko OV, Eckert C, von Stackelberg A, Aleinikova OV.

Leuk Res. 2011 Oct;35(10):1312-20. doi: 10.1016/j.leukres.2011.04.013. Epub 2011 May 18.

PMID:
21596436
13.

[Monitoring of minimal residual disease in children with acute lymphoblastic leukemia and its prognostic significance].

Xu XJ, Tang YM, Song H, Shi SW, Yang SL, Shen HQ, Wei J, Xu WQ, Pan BH, Zhao FY.

Zhonghua Er Ke Za Zhi. 2010 Mar;48(3):180-4. Chinese.

PMID:
20426951
14.

High CD45 surface expression determines relapse risk in children with precursor B-cell and T-cell acute lymphoblastic leukemia treated according to the ALL-BFM 2000 protocol.

Cario G, Rhein P, Mitlöhner R, Zimmermann M, Bandapalli OR, Romey R, Moericke A, Ludwig WD, Ratei R, Muckenthaler MU, Kulozik AE, Schrappe M, Stanulla M, Karawajew L.

Haematologica. 2014 Jan;99(1):103-10. doi: 10.3324/haematol.2013.090225. Epub 2013 Aug 2.

15.

Minimal residual disease values discriminate between low and high relapse risk in children with B-cell precursor acute lymphoblastic leukemia and an intrachromosomal amplification of chromosome 21: the Austrian and German acute lymphoblastic leukemia Berlin-Frankfurt-Munster (ALL-BFM) trials.

Attarbaschi A, Mann G, Panzer-Grümayer R, Röttgers S, Steiner M, König M, Csinady E, Dworzak MN, Seidel M, Janousek D, Möricke A, Reichelt C, Harbott J, Schrappe M, Gadner H, Haas OA.

J Clin Oncol. 2008 Jun 20;26(18):3046-50. doi: 10.1200/JCO.2008.16.1117.

16.

Effect of microRNA-210 on prognosis and response to chemotherapeutic drugs in pediatric acute lymphoblastic leukemia.

Mei Y, Gao C, Wang K, Cui L, Li W, Zhao X, Liu F, Wu M, Deng G, Ding W, Jia H, Li Z.

Cancer Sci. 2014 Apr;105(4):463-72. doi: 10.1111/cas.12370. Epub 2014 Mar 30.

17.

Clinical features and outcome of children with first marrow relapse of acute lymphoblastic leukemia expressing BCR-ABL fusion transcripts. BFM Relapse Study Group.

Beyermann B, Agthe AG, Adams HP, Seeger K, Linderkamp C, Goetze G, Ludwig WD, Henze G.

Blood. 1996 Feb 15;87(4):1532-8.

18.

Therapeutic effectiveness of the ALL-XH-99 protocol for childhood acute lymphoblastic leukemia.

Wang YR, Jin RM, Xu JW, Xiao Y, Zhou DF, Zhang ZQ.

Zhongguo Dang Dai Er Ke Za Zhi. 2008 Feb;10(1):1-4.

PMID:
18289459
19.

[Minimal residual disease analysis in acute lymphoblastic leukemia of childhood within the framework of COALL Study: results of an induction therapy without asparaginase].

zur Stadt U, Harms DO, Schlüter S, Jorch N, Spaar HJ, Nürnberger W, Völpel S, Gutjahr P, Schrappe M, Janka G, Kabisch H.

Klin Padiatr. 2000 Jul-Aug;212(4):169-73. German.

PMID:
10994545
20.

[Preliminary results of the use of MRD test among children with acute lymphoblastic leukaemia].

Raciborska A, Wypych A, Rokicka-Milewska R, Siedlecki JA, Kulik J.

Przegl Lek. 2004;61 Suppl 2:62-6. Polish.

PMID:
15686049
Items per page

Supplemental Content

Write to the Help Desk